Sun Set To Get Taro Deal Over The Line, 17 Years After First Trying

Indian Firm Owns 78.5% Of Taro; Paying $43 Per Share For Remainder

 
• By Dean Rudge
  
M&A
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Archive

More from Generics Bulletin